Nordea Equity Research raised Novo Nordisk A/S from a “hold” rating to a “buy” rating in a research report on Friday, June 19th. Finally, Citigroup reissued a “neutral” rating on shares of Novo Nordisk A/S in a research report on Monday, July 20th. Get Novo Nordisk A/S alerts:Get Our Latest Report on Novo Nordisk A/SNovo Nordisk A/S News RoundupNovo Nordisk A/S Stock PerformanceHere are the key news stories impacting Novo Nordisk A/S this week:NVO stock opened at $44.48 on Thursday. Novo Nordisk A/S has a twelve month low of $35.12 and a twelve month high of $64.16. See AlsoReceive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.